By Antonio Sánchez-Gijón, via capitalmadrid | In little more than fifty years, Egypt has gone from being the country with almost absolute power to regulate the use of the Nile, to be forced to negotiate with all countries upstream.

CdM | Oryzon Genomics has announced that the Mexican Patent Office has issued a decision to grant patent application MX/a/2021/011610, entitled ‘Combinations of iadademstat for cancer therapy’. The approved claims protect the use of iadademstat in combination with PD1 or PD-L1 inhibitors for the treatment of cancer, including small cell lung cancer (SCLC). Once formally granted, the patent is expected to provide protection until at least 2040, not including possible…